Improved graft survival in 100 retransplant recipients following AHG-negative crossmatching

被引:3
作者
Kerman, RH
Susskind, B
Slaton, J
Lewis, RM
Heydari, A
Ruth, J
Williams, J
VanBuren, CT
Katz, SM
Kahan, BD
机构
关键词
D O I
10.1016/S0041-1345(96)00562-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1451 / 1453
页数:3
相关论文
共 9 条
[2]  
CHO YW, 1994, CLIN TRANSPLANTS 199, P469
[3]  
GAROVOY MR, 1985, TRANSPLANT IMMUNOL L, V5, P1
[4]   THE ABILITY OF PRETRANSPLANT TEST-DOSE PHARMACOKINETIC PROFILES TO REDUCE EARLY ADVERSE EVENTS AFTER RENAL-TRANSPLANTATION [J].
KAHAN, BD ;
WELSH, M ;
RUTZKY, L ;
LEWIS, R ;
KNIGHT, R ;
KATZ, S ;
NAPOLI, K ;
GREVEL, J ;
VANBUREN, CT .
TRANSPLANTATION, 1992, 53 (02) :345-351
[5]  
KAHAN BD, 1982, TRANSPLANTATION, V34, P36, DOI 10.1097/00007890-198207000-00007
[6]   IMPROVED GRAFT-SURVIVAL FOR FLOW-CYTOMETRY AND ANTIHUMAN GLOBULIN CROSSMATCH-NEGATIVE RETRANSPLANT RECIPIENTS [J].
KERMAN, RH ;
VANBUREN, CT ;
LEWIS, RM ;
DEVERA, V ;
BAGHDAHSARIAN, V ;
GEROLAMI, K ;
KAHAN, BD .
TRANSPLANTATION, 1990, 49 (01) :52-56
[7]  
OGURA K, 1993, TRANSPLANTATION, V56, P294
[8]  
OGURA K, 1991, CLIN TRANSPLANTS 199, P471
[9]  
SCORNIK JC, 1994, TRANSPLANTATION, V57, P621